Targeting of low-dose CT screening according to the risk of lung-cancer death

New England Journal of Medicine

Volumn 369, Issue 3, 2013, Pages 245-254

  Kovalchik, Stephanie A ^a   Tammemagi, Martin ^c   Berg, Christine D ^a   Caporaso, Neil E ^a   Riley, Tom L ^b   Korch, Mary ^b   Silvestri, Gerard A ^d   Chaturvedi, Anil K ^a   Katki, Hormuzd A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c BROCK UNIVERSITY   (Canada)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCREENING TEST; THORAX RADIOGRAPHY; CONTROLLED CLINICAL TRIAL; LABORATORY DIAGNOSIS; LUNG; LUNG TUMOR; MASS SCREENING; MIDDLE AGED; MORTALITY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RISK; SMOKING;

AGED; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; RADIATION DOSAGE; RISK; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

MLCS; MLOWN;

EID: 84880560754     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1301851     Document Type: Article

References (33)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
2. The National Lung Screening Trial Research Team. Reduced lung cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
3. Cigarette smoking among adults and trends in smoking cessation - United States, 2008. MMWR Morb Mortal Wkly Rep 2009;58:1227-32.
4. Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012;307:2418-29. [Erratum, JAMA 2012;308:1324.]
5. Wender R, Fontham ET, Barrera E Jr, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013;63:107-17.
6. Couraud S, Cortot AB, Greillier L, et al. From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French Intergroup (IFCT) and the Groupe d'Oncologie de Langue Francaise (GOLF). Ann Oncol 2013;24:586-97.
7. Wood DE, Eapen GA, Ettinger DS, et al. Lung cancer screening. J Natl Compr Canc Netw 2012;10:240-65.
8. Jaklitsch MT, Jacobson FL, Austin JH, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012;144:33-8.
9. Raji OY, Duffy SW, Agbaje OF, et al. Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study. Ann Intern Med 2012;157:242-50.
10. Tammemägi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013;368:728-36.
11. Pinsky PF, Berg CD. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered? J Med Screen 2012;19:154-6.
12. Maisonneuve P, Bagnardi V, Bellomi M, et al. Lung cancer risk prediction to select smokers for screening CT: a model based on the Italian COSMOS Trial. Cancer Prev Res (Phila) 2011;4:1778-89.
13. Young RP, Hopkins RJ, Midthun DE. Computed tomographic screening for lung cancer. JAMA 2012;308:1320.
14. Jett JR, Midthun DE. Screening for lung cancer: for patients at increased risk for lung cancer, it works. Ann Intern Med 2011;155:540-2.
15. Bach PB, Gould MK. When the average applies to no one: personalized decision making about potential benefits of lung cancer screening. Ann Intern Med 2012;157:571-3.
16. National Lung Screening Trial Research Team. The National Lung Screening Trial: overview and study design. Radiology 2011;258:243-53.
17. Aberle DR, Adams AM, Berg CD, et al. Baseline characteristics of participants in the randomized National Lung Screening Trial. J Natl Cancer Inst 2010;102:1771-9. [Erratum, J Natl Cancer Inst 2011;103:1560.]
18. Benichou J, Gail MH. Estimates of absolute cause-specific risk in cohort studies. Biometrics 1990;46:813-26. (Pubitemid 20333612)
19. Tibshirani R. The lasso method for variable selection in the Cox model. Stat Med 1997;16:385-95. (Pubitemid 27073009)
20. Taylor JM, Ankerst DP, Andridge RR. Validation of biomarker-based risk prediction models. Clin Cancer Res 2008;14:5977-83.
21. Oken MM, Marcus PM, Hu P, et al. Baseline chest radiograph for lung cancer detection in the randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Natl Cancer Inst 2005;97:1832-9. (Pubitemid 43039889)
22. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002;21:1559-73. (Pubitemid 34746063)
23. Bach PB, Kattan MW, Thornquist MD, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003;95:470-8. (Pubitemid 36432421)
24. Spitz MR, Hong WK, Amos CI, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007;99:715-26. (Pubitemid 47073532)
25. Cassidy A, Myles JP, van Tongeren M, et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008;98:270-6. (Pubitemid 351161249)
26. Tammemagi CM, Pinsky PF, Caporaso NE, et al. Lung cancer risk prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst 2011;103:1058-68.
27. R Development Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2012.
28. Silvestri GA. Screening for lung cancer: it works, but does it really work? Ann Intern Med 2011;155:537-9.
29. Boiselle PM. Computed tomography screening for lung cancer. JAMA 2013;309:1163-70.
30. Heuvers ME, Stricker BH, Aerts JG. Generalizing lung-cancer screening results. N Engl J Med 2012;366:192-3.
31. Sox HC. Better evidence about screening for lung cancer. N Engl J Med 2011;365:455-7.
32. O'Connor GT, Hatabu H. Lung cancer screening, radiation, risks, benefits, and uncertainty. JAMA 2012;307:2434-5.
33. Barnes PM, Ward BW, Freeman G, et al. Early release of selected estimates based on data from the January-March 2011 National Health Interview Survey. National Center for Health Statistics, September 2011 (http://www.cdc.gov/nchs/ nhis.htm).